CBX2 and breast carcinoma: Considering the complex and heterogeneous nature of glycolytic regulation concerning the players and mechanism involved [58, 59, 60, 61], unraveling the mTORC1‐mediated metabolic roles CBX2 and CBX7 may improve our understanding about how glucose metabolism is regulated in breast cancer.